Cardiovascular
Cardiovascular(心血管)
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
- Acute Phase Reactants(17)
- Angina(14)
- Arrhythmia(85)
- Atherosclerosis(93)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(46)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(131)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(10)
- Endothelium(35)
- Erythrocytes & Hemoglobin(53)
- Heart Failure(32)
- Hypertension(167)
- Hypotension(24)
- Lipoproteins(66)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(64)
- Others(53)
- Serum Proteins(11)
- Smooth Muscle Cells(37)
- Storage & Transport(6)
- Stroke(53)
- Vasoconstriction(61)
- Thrombosis(58)
- Vasodilation(146)
Cardiovascular 相关产品(860)
- GC46845Amlodipine-d4 (maleate)CAS: 1185246-15-4纯度: >99.00%
An internal standard for the quantification of amlodipine
- GC46856Angiotensin II (5-8) (human, rat, mouse) (trifluoroacetate salt)纯度: >95.00%
An endogenous angiotensin II fragment
- GC46879Argatroban-d3 (hydrochloride)CAS: 1356847-56-7纯度: >99.00%
An internal standard for the quantification of argatroban
- GC46890Atorvastatin-d5 (calcium salt)CAS: 222412-82-0纯度: >99.00%
An internal standard for the quantification of atorvastatin
- GC46911Beauveriolide ICAS: 154491-55-1纯度: >95.00%
A cyclodepsipeptide inhibitor of lipid droplet formation
- GC46913Benazepril-d5 (hydrochloride)CAS: 1279026-26-4纯度: >99.00%
An internal standard for the quantification of benazapril
- GC46986C18 Ceramide-1-phosphate-d3 (d18:1/18:0-d3)CAS: 2692624-25-0纯度: >99.00%
A neuropeptide with diverse biological activities
- GC47021Caloxin 2A1 (trifluoroacetate salt)纯度: >98.00%
A neuropeptide with diverse biological activities
- GC47045Carvedilol-d5CAS: 929106-58-1纯度: >99.00%
An internal standard for the quantification of carvedilol
- GC47085Cholesterol-d7CAS: 83199-47-7纯度: >99.00%
An internal standard for the quantification of cholesterol
- GC47088Cilostazol-d4CAS: 1215541-47-1纯度: >99.00%
An internal standard for the quantification of cilostazol
- GC47103Clonidine-d4 (hydrochloride)CAS: 67151-02-4纯度: >99.00%
An internal standard for the quantification of clonidine
- GC47116Coenzyme Q10-d6CAS: 110971-02-3纯度: >99.00%
An internal standard for the quantification of CoQ 10
- GC47120Conivaptan-d4CAS: 1129433-63-1纯度: >99.00%
An internal standard for the quantification of conivaptan
- GC47165Dabigatran etexilate-d13CAS: 2749293-92-1纯度: >99.00%
A neuropeptide with diverse biological activities
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC46845 | Amlodipine-d4 (maleate) | 1185246-15-4 | >99.00% | |
An internal standard for the quantification of amlodipine | ||||
| GC46856 | Angiotensin II (5-8) (human, rat, mouse) (trifluoroacetate salt) | - | >95.00% | |
An endogenous angiotensin II fragment | ||||
| GC46879 | Argatroban-d3 (hydrochloride) | 1356847-56-7 | >99.00% | |
An internal standard for the quantification of argatroban | ||||
| GC46889 | Atorvastatin (calcium salt hydrate) | 357164-38-6 | >98.00% | |
An HMG-CoA reductase inhibitor | ||||
| GC46890 | Atorvastatin-d5 (calcium salt) | 222412-82-0 | >99.00% | |
An internal standard for the quantification of atorvastatin | ||||
| GC46894 | Atropine-d5 | 2124269-77-6 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46911 | Beauveriolide I | 154491-55-1 | >95.00% | |
A cyclodepsipeptide inhibitor of lipid droplet formation | ||||
| GC46912 | Beauveriolide III | 221111-70-2 | >95.00% | |
Beauveriolide III 是小鼠巨噬细胞中脂滴形成的抑制剂。 | ||||
| GC46913 | Benazepril-d5 (hydrochloride) | 1279026-26-4 | >99.00% | |
An internal standard for the quantification of benazapril | ||||
| GC46986 | C18 Ceramide-1-phosphate-d3 (d18:1/18:0-d3) | 2692624-25-0 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47021 | Caloxin 2A1 (trifluoroacetate salt) | - | >98.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47045 | Carvedilol-d5 | 929106-58-1 | >99.00% | |
An internal standard for the quantification of carvedilol | ||||
| GC47053 | CAY10746 | 2247240-76-0 | >95.00% | |
A ROCK1 and ROCK2 inhibitor | ||||
| GC47085 | Cholesterol-d7 | 83199-47-7 | >99.00% | |
An internal standard for the quantification of cholesterol | ||||
| GC47088 | Cilostazol-d4 | 1215541-47-1 | >99.00% | |
An internal standard for the quantification of cilostazol | ||||
| GC47096 | Citrinin-13C13 | - | >98.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47100 | Clevidipine-d7 | 2747918-66-5 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47103 | Clonidine-d4 (hydrochloride) | 67151-02-4 | >99.00% | |
An internal standard for the quantification of clonidine | ||||
| GC47116 | Coenzyme Q10-d6 | 110971-02-3 | >99.00% | |
An internal standard for the quantification of CoQ 10 | ||||
| GC47120 | Conivaptan-d4 | 1129433-63-1 | >99.00% | |
An internal standard for the quantification of conivaptan | ||||
| GC47135 | CV-6209-d5 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47149 | Cyclopiazonic Acid-13C20 | - | >98.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47165 | Dabigatran etexilate-d13 | 2749293-92-1 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47175 | Deacetylforskolin | 64657-20-1 | >98.00% | |
A diterpene with diverse biological activities | ||||